Merge Labs is a research laboratory focused on developing fundamentally new brain-computer interfaces (BCIs). The company's approach diverges from conventional electrode-based methods by employing molecules and ultrasound to interact with the brain at high bandwidth. Its stated long-term mission is to bridge biological and artificial intelligence, with the goal of maximizing human ability, agency, and experience.
The company operates in the neurotechnology and AI research verticals, with a presence in the San Francisco Bay Area. Merge Labs has secured significant funding, with capital raised exceeding $250 million to support its research and development efforts in these technically demanding fields.
